Prehospital Triage of Patients With Suspected Non-ST-segment Elevation Acute Coronary Syndrome: the TRIAGE-ACS Study
Launched by CATHARINA ZIEKENHUIS EINDHOVEN · Feb 7, 2022
Trial Information
Current as of May 14, 2025
Completed
Keywords
ClinConnect Summary
No description provided
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Chest pain suspected for NSTE-ACS
- • Age ≥ 18 years
- • Intention to transfer patient to Emergency Department
- Exclusion Criteria:
- • ST-segment elevation Acute Coronary Syndrome
- • Post resuscitation patients
- • Hemodynamic instability defined as Killip Class IV
- • Suspected other life treating pathology
- • Pregnancy
- • No informed consent for data usage
About Catharina Ziekenhuis Eindhoven
Catharina Ziekenhuis Eindhoven is a leading healthcare institution in the Netherlands, dedicated to delivering high-quality patient care and advancing medical research. As a prominent clinical trial sponsor, the hospital is committed to facilitating innovative research initiatives that aim to improve treatment outcomes and enhance patient quality of life. With a diverse range of medical specialties and a collaborative approach, Catharina Ziekenhuis Eindhoven fosters an environment that supports rigorous clinical trials, ensuring adherence to ethical standards and regulatory guidelines while prioritizing patient safety and well-being. Through its robust infrastructure and expertise, the hospital actively contributes to the development of new therapies and medical technologies, playing a vital role in the evolution of healthcare.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Eindhoven, Noord Brabant, Netherlands
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials